Addendum: Mutually exclusive lymphangiogenesis or perineural infiltration in human skin squamous-cell carcinoma

Julien Schaller; Hélène Maby-El Hajjami; Sylvie Rusakiewicz; Kalliopi Ioannidou; Nathalie Piazzon; Alexandra Miles; Déla Golshayan; Olivier Gaide; Daniel Hohl; Daniel E. Speiser; Karin Schaeuble

doi:10.18632/oncotarget.28319

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Addendum:

Addendum: Mutually exclusive lymphangiogenesis or perineural infiltration in human skin squamous-cell carcinoma

PDF | How to cite

Oncotarget. 2022; 13:1299-1299. https://doi.org/10.18632/oncotarget.28319

Metrics: PDF 728 views | ?

Julien Schaller¹, Hélène Maby-El Hajjami¹, Sylvie Rusakiewicz¹, Kalliopi Ioannidou², Nathalie Piazzon², Alexandra Miles³, Déla Golshayan⁴, Olivier Gaide³, Daniel Hohl³, Daniel E. Speiser¹ and Karin Schaeuble¹

¹Department of Oncology, University Hospital Lausanne (CHUV/UNIL), Lausanne, Switzerland
²Institute of Pathology, University Hospital Lausanne (CHUV), Lausanne, Switzerland
³Department of Dermatology, University Hospital Lausanne (CHUV), Lausanne, Switzerland
⁴Transplantation Center, University Hospital Lausanne (CHUV/UNIL), Lausanne, Switzerland

Published: December 06, 2022

Copyright: © 2022 Schaller et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has an addendum: The skin squamous-cell carcinoma (sSCC) samples were collected and used in compliance with the study protocol n°2016-01851, approved by Commission cantonale d’éthique de la recherche sur l’être humain du canton de Vaud (CER-VD), in line with the legal requirements. Patients signed a general consent for use of health-related data.

Original article: Oncotarget. 2021; 12:638–648. DOI: https://doi.org/10.18632/oncotarget.27915

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28319

Publication Alerts

Post-Publication Promotion

Addendum:

Addendum: Mutually exclusive lymphangiogenesis or perineural infiltration in human skin squamous-cell carcinoma